Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian A J J Jaspers

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Lancet (London, England)|January 30, 2007
Onchocerciasis or loiasis?Cornelus J G Sanders, Christian A J J Jaspers
Blood Cells, Molecules & Diseases|November 29, 2007
A novel (Leu183Pro-)mutation in the HFE-gene co-inherited with the Cys282Tyr mutation in two unrelated Dutch hemochromatosis patientsDorine W Swinkels, Hanka Venselaar, Erwin T Wiegerinck, et al.
The Journal of Infectious Diseases|July 25, 2009
Failure of treatment with first-line lopinavir boosted with ritonavir can be explained by novel resistance pathways with protease mutation 76VMonique Nijhuis, Annemarie M J Wensing, Wouter F W Bierman, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|January 30, 2007
Onchocerciasis or loiasis?Cornelus J G Sanders, Christian A J J Jaspers
Blood Cells, Molecules & Diseases|November 29, 2007
A novel (Leu183Pro-)mutation in the HFE-gene co-inherited with the Cys282Tyr mutation in two unrelated Dutch hemochromatosis patientsDorine W Swinkels, Hanka Venselaar, Erwin T Wiegerinck, et al.
The Journal of Infectious Diseases|July 25, 2009
Failure of treatment with first-line lopinavir boosted with ritonavir can be explained by novel resistance pathways with protease mutation 76VMonique Nijhuis, Annemarie M J Wensing, Wouter F W Bierman, et al.
Pageof 1